Frank Bernier on Nature Aging Breakthrough: Urolithin A Just Scored a Big Win for Immune Aging
Frank Bernier, R&D Unit Leader at GLICO, posted on LinkedIn:
”Urolithin A just scored a big win for immune aging.
A new randomized, double-blind, placebo-controlled trial in Nature Aging asked a simple question: if we improve mitochondrial quality, can we make aging immune cells act young again?
Healthy middle-aged adults took Urolithin A (1,000 mg/day) for 4 weeks. The results:
• ↑ Naive-like CD8⁺ T cells
• ↓ Terminally exhausted CD8⁺ T cells
• ↑ Fatty acid oxidation capacity in CD8⁺ T cells
• ↑ Mitochondrial biogenesis in immune cells
• ↑ NK cells and nonclassical monocytes
• Better functional responses (TNF secretion, bacterial uptake)
In other words: tuning mitophagy and mitochondria did not just support immunity in theory. It shifted real human immune cell phenotypes toward a more resilient, “younger” state in weeks.
Longevity is not only about adding years. It is about preserving immune memory, surveillance, and metabolic fitness so the system can still recognise, respond, and repair.
For anyone working in nutrition, microbiome, or healthy aging, this is a strong signal: mitochondria are not a side character. They are a primary target.
Article (Open Access) here.”
Title: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Authors: Dominic Denk, Anurag Singh, Herbert G. Kasler, Davide D’Amico, Julia Rey, Lucía Alcober-Boquet, Johanna M. Gorol, Christoph Steup, Ritesh Tiwari, Ryan Kwok, Rafael J. Argüello, Julie Faitg, Kathrin Sprinzl, Stefan Zeuzem, Valentina Nekljudova, Sibylle Loibl, Eric Verdin, Chris Rinsch, Florian R. Greten
Stay updated with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology